January 04, 2021
A Florida federal judge presiding over sprawling multidistrict litigation over the carcinogens found in the popular heartburn medication Zantac has held that state labeling and design defect claims against Zantac generics makers, repackagers, retailers and distributors are preempted by federal law.
December 15, 2020
Drugmakers, retailers and distributors targeted in the multidistrict litigation over heartburn medication Zantac told a Florida federal court on Tuesday that plaintiffs' state law claims over alleged design and labeling defects are preempted by federal law.
December 14, 2020
Drugmakers ensnared in the multidistrict litigation over heartburn medication Zantac rattled off a litany of problems with the plaintiffs' claims to a Florida federal judge on Monday, calling them "shotgun pleadings" that improperly lump together all defendants and fail to allege injury.
May 12, 2020
Drugmakers caught up in the multidistrict litigation over heartburn medication Zantac told a Florida federal court Tuesday the lawsuits are "based on a series of mights and maybes," saying there's no evidence of a causal link between the drug and cancer.
May 11, 2020
A Florida federal judge created a novel leadership structure for the team representing plaintiffs in multidistrict litigation over heartburn medication Zantac in an attempt to give qualified but inexperienced attorneys a chance to play a meaningful role in what is shaping up to be a major MDL in the federal court docket.